CNTO 136

· Centocor, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for CNTO 136, covering 2010-04-27 to 2017-12-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Effectiveness and Safety of CNTO 136 in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy [Phase 2]

See pricing